Pharmaceutical Heavy Metals Detection Now Requires High Technology Equipment

For many organisations the changes will implicate a considerable investment in equipment, training & technology. This can remove valuable resources from the pharmaceutical value chain, limiting the focus of research and development. Instead of investing in the skills and knowledge to develop this in house partnering with a CRO will reduce cost & increase speed to market.

Now is the time to seek out a Contract Research Organisation (CRO) with the capabilities, knowledge and resources.

Without the large capital investment required from the Pharmaceutical company International Laboratory Services can develop and validate methodology for the detection and quantification of the particular heavy metals used in the drug development process at an fraction of the cost of keeping the analysis in house.

For more information about the changes to the Pharmaceutical Heavy Metals Detection, please click here or visit the Pharmaceutical Industry Information section of our website.